Evidence map›Paper›PMID 34671065›Full record

ArticleScientific reports2021

Dynamic FRET-FLIM based screening of signal transduction pathways.

Rolf Harkes, Olga Kukk, Sravasti Mukherjee, Jeffrey Klarenbeek, Bram van den Broek, Kees Jalink

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Rolf Harkes *Cell Biophysics Group, Department of Cell Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Olga Kukk *Cell Biophysics Group, Department of Cell Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Sravasti MukherjeeCell Biophysics Group, Department of Cell Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Jeffrey KlarenbeekCell Biophysics Group, Department of Cell Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Bram van den BroekCell Biophysics Group, Department of Cell Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Kees JalinkCell Biophysics Group, Department of Cell Biology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. k.jalink@nki.nl.
The Netherlands Cancer Institute · NLUniversity of Amsterdam · NL

Funding

Marie Curie 840088
6 · The paper itself

Abstract

Fluorescence Lifetime Imaging (FLIM) is an intrinsically quantitative method to screen for protein-protein interactions and is frequently used to record the outcome of signal transduction events. With new highly sensitive and photon efficient FLIM instrumentation, the technique also becomes attractive to screen, with high temporal resolution, for fast changes in Förster Resonance Energy Transfer (FRET), such as those occurring upon activation of cell signaling. The second messenger cyclic adenosine monophosphate (cAMP) is rapidly formed following activation of certain cell surface receptors. cAMP is subsequently degraded by a set of phosphodiesterases (PDEs) which display cell-type specific expression and may also affect baseline levels of the messenger. To study which specific PDEs contribute most to cAMP regulation, we knocked down individual PDEs and recorded breakdown rates of cAMP levels following transient stimulation in HeLa cells stably expressing the FRET/FLIM sensor, Epac-S

Indexed as

Cell Line, TumorCyclic AMPFluorescenceFluorescence Resonance Energy TransferHeLa CellsHumansMicroscopy, FluorescenceOptical ImagingPhosphoric Diester HydrolasesPhotonsProteinsSignal TransductionCyclic AMPPhosphoric Diester HydrolasesProteins

Identifiers

PMID34671065
PMCPMC8528867
OpenAlexW3207269130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.